on admission – Page 14 – Communicable Diseases Research

Kidney function on admission predicts in-hospital mortality in COVID-19

입원 시 신장 기능, COVID-19에서 병원 내 사망률 예측

Research Article

Published on 2020-09-032022-08-13
Journal: PLoS ONE [Category] Biochemistry, COVID-19, MERS,

Initial clinical features of suspected coronavirus disease 2019 in two emergency departments outside of Hubei, China

중국 후베이성 외 2개 응급실에서 의심되는 코로나바이러스 질병 2019의 초기 임상 특징

Article

Published on 2020-09-012022-09-11
Journal: Journal of medical virology [Category] SARS, 바이오마커,

[키워드] Admission Admissions Bilateral case report form Chest computed tomography chest CT scan China Clinical data clinical feature clinics collected Computed tomography coronavirus coronavirus disease Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) COVID-19 COVID-19 patient diagnosed Emergency Departments enrolled epidemiological Epidemiology exposure to Features Fever GGO ground-glass opacity history illness onset Infection initial Laboratory results lymphopenia majority median age median time number of admissions on admission Patient patients Pneumonia referred to Symptoms uninfected virus virus classification Wuhan
[DOI] 10.1002/jmv.25763 PMC 바로가기 [Article Type] Article

Frequency and Type of Red Flags in Patients With Covid-19 and Headache: A Series of 104 Hospitalized Patients

Covid-19 및 두통 환자의 위험 신호 빈도 및 유형: 104명의 입원 환자 시리즈

Observational Study

Published on 2020-09-012022-09-11
Journal: Headache [Category] SARS, 바이오마커, 임상,

muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized controlled trial

코비드-19-실험 약물 및 기전(TACTIC-E)으로 입원한 ICu 전 환자에 대한 다중 암 치료 연구: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약

Letter

Published on 2020-07-312022-08-13
Journal: Trials [Category] SARS, 임상,

[키워드] able to swallow adaptive Adaptive trial added Admission age Ambrisentan Analysis approved Arm ARMS balloon pump balloon pump) baseline benefit Biomarker blinded Blinding calculated Cambridge Cambridge University Hospitals NHS Foundation Trust can not cardiac cardiovascular complications cells clearance clinical endpoint Clinical endpoints clinical picture clinically Combination comparator comparison Complete Composite Course COVID-19 COVID-19 infection creatinine creatinine clearance CRP Dapagliflozin Data analysis Day death defined demonstrated determine diabetes Diagnosis discretion disease dissemination drug drugs ECMO EDP1815 Efficacy element enrolled envelope EU Clinical Trial EU Clinical Trials EudraCT Evidence evidence of exclusion criteria Experimental drugs failure feature fixed foundation Gault Gender group hypertension immunomodulation immunomodulatory incidence include Inclusion independent independent data monitoring committee Inotropes Intervention Invasive mechanical ventilation investigator Laboratory late stage male mechanism membrane neutrophil Neutrophils NHS number objective Occurrence on admission once daily Open-label open-label trial opinion option Organ failure organ support Other outcome Oxygenation pandemic Parallel Arm participant Patient patients with COVID-19 performed phase platform Platform trial positive positive COVID-19 predicted Primary outcome principal investigator progression protocol Radiographic radiological randomisation randomised Randomized controlled trial recruited reduce Registered related disease renal renal failure risk Sample size severity Standard of care status stratified Study protocol subject Support tablets the patient therapy Treatment treatment arm Trial Trial registration triggered Trust university website
[DOI] 10.1186/s13063-020-04618-2 PMC 바로가기 [Article Type] Letter

Clinical characteristics of 82 cases of death from COVID-19

코로나19 사망자 82명의 임상적 특징

Research Article

Published on 2020-07-092022-08-13
Journal: PLoS ONE [Category] Biochemistry, COVID-19, MERS, SARS,

[키워드] Admission age Alanine alanine aminotransferase aspartate Aspartate aminotransferase association C-reactive protein Cancer cardiac failure cause of death caused Cerebrovascular disease Characteristics clinical Clinical characteristics Clinical data Comorbidities Comorbidity COVID-19 cytokine cytokine release Cytokine release syndrome D-dimer Data collection death death case detected patients develop diabete diabetes diagnosed died disease electronic medical record followed by forms heart disease hemorrhage Hemorrhagic hemorrhagic damage hypertension ICU IL-6 initial symptom initial symptoms IQR laboratory-confirmed Lactate lactate dehydrogenase Local lymphocyte lymphopenia male mechanical ventilation support median age median time medical records MOST Most patient Most patients neutrophil Neutrophil-to-lymphocyte ratio neutrophilia Older on admission other organs oxygen Patient patients Pneumonia proportion remained renal renal damage renal failure respiratory Respiratory failure SARS-CoV-2 SARS-COV-2 infection Sepsis severe disease single center Spread systemic immune-inflammation index the median the patient thrombocytopenia treated virus Wuhan Wuhan local hospital’ Wuhan, China
[DOI] 10.1371/journal.pone.0235458 PMC 바로가기 [Article Type] Research Article

Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients – mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 – Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial

ICu 전 환자의 Covid-19에 대한 용도 변경 면역조절 약물 - Covid-19로 입원한 ICu 전 환자에 대한 다중 암 치료 연구 – 용도 변경 약물(TACTIC-R): 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약

Letter

Published on 2020-07-082022-08-13
Journal: Trials [Category] SARS, 임상,

[키워드] Administered Admission age Analysis Arm ARMS balloon pump balloon pump) Baricitinib baseline blinded Blinding calculated Cambridge Cambridge University Hospitals NHS Foundation Trust can not candidate cardiac clearance clinical picture college comparator comparison Complete COVID-19 infection creatinine creatinine clearance CRP Data analysis Data monitoring committee Day death defined determine diabetes Diagnosis discharge disease dissemination dose drug Drug evaluation Efficacy element enrolled envelope EU Clinical Trial EU Clinical Trials EudraCT event exclusion criteria feature fixed foundation Gault Gender hypertension IDMC immunomodulatory immunomodulatory drug immunomodulatory drugs Immunomodulatory therapies immunomodulatory therapy incidence include Inclusion independent data monitoring committee initial Inotropes interim analysis Intervention intravenously Invasive mechanical ventilation investigator ISRCTN late stage Local male membrane neutrophil Neutrophils NHS number objective on admission once daily Open-label open-label trial opinion Organ failure organ support outcome Oxygenation participant Patient phase Platform trial positive positive COVID-19 predicted Primary outcome progression Prophylaxis protocol Radiographic radiological randomisation randomised randomised controlled trial Ravulizumab recruited recruitment reduce reduced regimen Registered related disease renal renal failure Repurposed drugs risk Sample size scalability selected severity SOC stage 2 Standard of care status stratified Study protocol subject Support Toxicity treatment arm Trial Trial registration triggered Trust university university hospital Venous Thromboembolism website
[DOI] 10.1186/s13063-020-04535-4 PMC 바로가기 [Article Type] Letter

Elevated levels of D-dimer in patients with COVID-19: prognosis value

COVID-19 환자의 D-dimer 수치 상승: 예후 가치

Research

Published on 2020-07-072022-09-10
Journal: The Pan African Medical Journal [Category] MERS, SARS, 바이오마커,

Daily consumption of ready-to-use peanut-based therapeutic food increased fat free mass, improved anemic status but has no impact on the zinc status of people living with HIV/AIDS: a randomized controlled trial

바로 사용할 수 있는 땅콩 기반 치료 식품을 매일 섭취하면 무지방 질량이 증가하고 빈혈 상태가 개선되지만 HIV/AIDS 감염자의 아연 상태에는 영향을 미치지 않습니다. 무작위 대조 시험

Research Article

Published on 2016-01-042022-08-09
Journal: BMC Public Health [Category] 임상,

[키워드] adjusted Admission affected AIDS Anemia anemic anemic status ART atomic absorption spectrometry Bio-Impedance Analysis Body body composition body fat body weight both groups clinical trial comparable Concentration conducted Control control group Controlled Controlled clinical trial CRP Daily daily recommended intake deficiency discharge energy fat Fat free mass fat-free mass food group hemoglobin HIV/AIDS Hospitalized Improving Individual dietary Infection iron Malnutrition measure muscle mass on admission patients percentage body fat plasma plasma zinc concentration PLWH positive Randomized controlled trial Randomly ready-to-use therapeutic food receive Recommended Dietary Allowances Registered remained Result Senegal severe malnutrition significantly standard hospital diet status sub-Saharan Africa the patient therapeutic Therapeutic food Treatment was determined was measured were measured Zinc zinc deficiency α1-AGP
[DOI] 10.1186/s12889-015-2639-8 PMC 바로가기 [Article Type] Research Article